Delcath Systems publishes subgroup analysis of cancer treatment study
Tweet Send to a Friend
Delcath Systems Inc. (NASDAQ: DCTH) announced the publication of subgroup analyses from its phase 3 FOCUS study in the Journal ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




